- Thank you, CBN medicalreporter Lorie Johnson is here
to shed light on what'shappening with the vaccine.
And Lorie, people are alreadyskittish about the vaccine.
Going to pounce on what this means,
the vaccine is unsafe,
what do you think?
- Well, actually, I thinkthe opposite is true, Pat.
It just goes to show
that these safety nets are in place.
What we have here is a hugetrial of 30,000 people,
and one person involved in the trial
has an unexplained illness.
Standard protocol that'salways been in place
for vaccine trials
is continuing in this one,
which means if anyone in the trial
has some sort of unexplained illness,
stop the presses,
stop injecting the vaccine
into the people in the trial,
look at this person, findout what the illness is,
and most importantly, wasit caused by the vaccine.
Could be completely unrelated,
but the point is
that this is a verystringent safety measure.
AstraZeneca is not sayinganything about this patient,
where the patient is, what the problem is,
although there is an unconfirmed report
that it's a person in the UK,
and the UK trial's separate and apart
from the United States trial,
and that this person reportedly has
an inflammatory conditionthat affects the spinal cord
and is caused by a virus.
Again, that's an unconfirmed report.
AstraZeneca is going to look into it,
and until then, no more people
are going to be inject with the vaccine,
although there are two othervery leading contenders.
We've got the Modernaone and the Pfizer one.
The CEO of Pfizer saidthat they may be finished
by the end of October.
- What do you think?
Are people gonna be scared of it,
or are they gonna be taking this vaccine?
- Well, I think both things.
We know that some people
are just automatically afraid of vaccines,
even before COVID-19,
and what we really need todo is look at the science.
And we know that thesevaccine makers have said,
look, we're going to moveahead with the science.
We're not going to let anypolitician influence us,
that when we have the sciencethat it is safe and effective,
we're going to recommend that to the FDA.
And when that happens,
the FDA gives it to anunbiased panel of experts,
and they look at all the data,
and then they make their recommendation.
So all these things have to happen.
There are lots of safety nets in place.
We know that the phaseone trial is about safety.
We know that healthy youngpeople were given it,
and they did get a good safety record.
Phase two trials was about does it work,
and that came out good,
and so phase three trials is to see
if it's safe and effectivein a huge number of people,
30,000 people, that'swhere we are right now.
So it's already beenproven safe and effective
in young, healthy people.
Now we need to look at it
in all different types of society,
African-Americans, people who are older,
and those who are themost seriously affected
by the COVID-19 virus.
- I understand it waschildren going back to school,
there have been a number of kids
that have gotten the COVID.
What's the story on that?
- A lot of kids.
So we know that about ahalf a million children
have COVID-19, have been diagnosed,
have gotten a positive diagnosis,
about half a million of them.
That makes up about 10% of all the cases.
And we know that, just inthe last couple of weeks,
that number has gone up about 17%
as the kids have gone back to school.
We know unfortunately, Pat,
that 103 children have died from COVID-19.
That's about in line
with how man children diefrom the flu each year.
Each year, about 90 to150 kids die from the flu,
swine flue, 300 kids.
And so we know that, statistically,
children dying fromCOVID-19 is zero to 0.3%.
18 states have reportedno childhood deaths
from COVID-19 so far.
- That's relatively good news.
Thanks Lorie for.
